Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

[1]  J. R. Landis,et al.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. , 1977, Biometrics.

[2]  B. Fornage,et al.  Clinical, mammographic, and sonographic determination of preoperative breast cancer size , 1987, Cancer.

[3]  J. Pain,et al.  Assessment of breast cancer size: a comparison of methods. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  J. Carlin,et al.  Bias, prevalence and kappa. , 1993, Journal of clinical epidemiology.

[5]  D. King,et al.  Mammography in the assessment of response to medical treatment of large primary breast cancer. , 1993, Clinical radiology.

[6]  W. Sauerbrei,et al.  Preoperative staging of breast cancer by palpation, mammography and high‐resolution ultrasound , 1993, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  M. Kaufmann,et al.  Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie , 1994 .

[8]  H. Junkermann,et al.  [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. , 1994, Geburtshilfe und Frauenheilkunde.

[9]  U. Chetty,et al.  Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment , 1994, The British journal of surgery.

[10]  J E Husband,et al.  Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. , 1996, Radiology.

[11]  M. Helvie,et al.  Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. , 1996, Radiology.

[12]  G. Hortobagyi,et al.  Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  W. Yang,et al.  Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. , 1997, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[14]  I. Smith,et al.  Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer. , 1997, British Journal of Cancer.

[15]  T. Powles,et al.  A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  W. Eiermann,et al.  Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  L. Esserman,et al.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. Khaled,et al.  Breast conservative surgery: is it appropriate for locally advanced breast cancer following downstaging by neoadjuvant chemotherapy? A pathological assessment. , 1999, Breast.

[20]  G. Hortobagyi,et al.  Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  I Zuna,et al.  Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress). , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[22]  S. Delorme,et al.  Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy. , 2000, Anticancer research.

[23]  F. Hoehler.  Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. , 2000, Journal of clinical epidemiology.

[24]  A. Wolff,et al.  Primary systemic therapy in operable breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  L. Pusztai,et al.  Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. , 2001, American journal of surgery.

[26]  T. Hieken,et al.  Correlating sonography, mammography, and pathology in the assessment of breast cancer size. , 2001, American journal of surgery.

[27]  C. V. D. van de Velde,et al.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Bryant,et al.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. , 2001, Journal of the National Cancer Institute. Monographs.

[29]  L. Carey,et al.  Long-Term Outcome of Neoadjuvant Therapy for Locally Advanced Breast Carcinoma: Effective Clinical Downstaging Allows Breast Preservation and Predicts Outstanding Local Control and Survival , 2002, Annals of surgery.

[30]  G. Hortobagyi,et al.  Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer. , 2002, European journal of cancer.

[32]  J. V. van Engelshoven,et al.  Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. , 2003, European journal of radiology.

[33]  M. Dewhirst,et al.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.

[34]  Hans-Peter Sinn,et al.  International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  L. Brunereau,et al.  Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[36]  C. Zuiani,et al.  Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy , 2004, European Radiology.

[37]  A. Rademaker,et al.  Prediction of breast cancer size by ultrasound, mammography and core biopsy. , 2004, Breast.

[38]  Roman Rouzier,et al.  Breast‐conserving surgery after neoadjuvant anthracycline‐based chemotherapy for large breast tumors , 2004, Cancer.

[39]  R. Warren,et al.  Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? , 2004, British Journal of Cancer.

[40]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[41]  M. Brizzi,et al.  Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease , 2001, Breast Cancer Research and Treatment.

[42]  M. Morrow,et al.  Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer. , 2005, Journal of the National Cancer Institute.

[43]  M. Bani,et al.  Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used? , 2005, Anticancer research.

[44]  L. Carey,et al.  American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. , 2005, Journal of the National Cancer Institute.

[45]  T. Bisgaard,et al.  Preoperative Assessment of Small Tumours in Women with Breast Cancer , 2005, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[46]  G. Cocconi,et al.  Problems in evaluating response of primary breast cancer to systemic therapy , 2005, Breast Cancer Research and Treatment.

[47]  G. Hortobagyi,et al.  Breast conservation after neoadjuvant chemotherapy , 2005, Cancer.

[48]  G. Schwartz,et al.  Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast. , 2005, Journal of the American College of Surgeons.

[49]  Dianne Georgian-Smith,et al.  Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. , 2005, AJR. American journal of roentgenology.

[50]  F. Peintinger,et al.  Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer , 2005, Anti-cancer drugs.

[51]  A. Tardivon,et al.  Monitoring therapeutic efficacy in breast carcinomas , 2006, European Radiology.

[52]  S. Singletary,et al.  Accuracy of the Combination of Mammography and Sonography in Predicting Tumor Response in Breast Cancer Patients After Neoadjuvant Chemotherapy , 2006, Annals of Surgical Oncology.

[53]  A. Seidman.  Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis , 2006 .

[54]  Yoshinobu Sato,et al.  Preoperative Evaluation of Residual Tumor Extent by Three‐Dimensional Magnetic Resonance Imaging in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy , 2006, The breast journal.

[55]  H. Khaled,et al.  Pathological Assessment of the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy and Its Implications for Surgical Management , 2010, Surgery Today.